Moderna | MRNA - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.83B 130M 2026-03
Arrowhead Research USD -141.26M 182.07M 2026-03
Biogen USD 514.3M 128.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Celltrion KRW 12.9B 822.77M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 8.14B 420M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Incyte USD 324.17M 59.7M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Moderna USD -1.39B 531M 2026-03
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pharma Mar EUR 622K 42.99M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Qiagen NV USD 121.88M 15.41M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Sartorius EUR 160.7M 9.5M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03